FDA stem cell warning Archives

Stem Cell Therapy for Degenerative Disc Disease: New 2026 Trial Data Explained

Quick Summary New 2026 Phase 2 data for BRTX-100 (autologous mesenchymal stem cell therapy for chronic lumbar disc disease) shows sustained pain and functional improvements at 52 weeks: 56% of evaluable patients had ≥50% VAS pain reduction, 64% had ≥50% ODI disability improvement. Safety data reported no dose-limiting toxicities or

May 28, 2026 No Comments

Stem Cell Therapy: Could It Transform Medicine and Slow Ageing?

Quick Summary Stem cell therapy is making measured progress toward treating age-related diseases like vision loss, frailty, and Parkinson’s, but broad age reversal remains unproven. Recent clinical trials show improved mobility in frailty patients, while Parkinson’s and vision repair trials aim to replace specific damaged cells. However, safety risks persist,

May 25, 2026 No Comments